Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Deyang Biochemical Products is a Chinese pharmaceutical manufacturer specializing in the production of biochemical APIs and intermediates derived from animal tissues. The company is a significant producer of heparin sodium and chondroitin sulfate, which are used globally in the treatment of cardiovascular diseases and joint health. Operating out of Sichuan province, the firm maintains large-scale manufacturing facilities that adhere to international quality standards to supply both domestic and export markets. Their business model focuses on the extraction and purification of complex biological molecules for use in finished dosage forms by other pharmaceutical companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Deyang Biochemical Products.